Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06192316 · ClinicalTrials.gov registry record · NA
Human Laboratory Study of the Effects of Nicotine Product Claims on Appeal, Perceptions, and Use Behavior
A NA study of Behavior, Risk, sponsored by Ohio State University Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 450
- Enrollment target
- 1
- Study location
NCT06192316: Recruiting NA study of Behavior, Risk, sponsored by Ohio State University Comprehensive Cancer Center.
NCT06192316 is a NA study of Behavior, Risk that is actively recruiting participants, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 450 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06192316, a NA study of Behavior, Risk, is actively recruiting participants, sponsored by Ohio State University Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 450 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates knowledge, feelings and thoughts regarding nicotine products among young adults who are susceptible to but do not use tobacco/nicotine and adults who use tobacco/nicotine.
Primary Outcome
Visual attention will be measured via eye movements using SmartEye AI-X eye tracker with a 60 Hz sampling rate. Areas of interest (AOIs) will be predefined for each pack image including: 1) Full pack image; 2) Nicotine concentration; 3) Nicotine source claim; 4) Branding (i.e., brand name, flavors); 5) Warning label. A primary outcome for visual attention will be dwell time on AOIs.
Conditions Studied
Interventions
- BEHAVIORAL 3x3 between-subjects experimental exposure
Study Locations (1)
Ohio
- Ohio State University Comprehensive Cancer Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2024-03-01 |
| Est. Completion | 2028-09-14 |
| Phase | NA |
What NCT06192316 shows while recruiting
NCT06192316 is an interventional study that assigns participants to a tested intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).
The record links to 1 condition, with Behavior, Risk appearing as the primary indexed condition, and to 1 intervention - of which 3x3 between-subjects experimental exposure is the first listed.
NCT06192316 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06192316 about?
NCT06192316 is a clinical study titled "Human Laboratory Study of the Effects of Nicotine Product Claims on Appeal, Perceptions, and Use Behavior". This study evaluates knowledge, feelings and thoughts regarding nicotine products among young adults who are susceptible to but do not use tobacco/nicotine and adults who use tobacco/nicotine.
What is the current status of trial NCT06192316?
This trial is currently recruiting. It is a NA study. The enrollment target is 450 participants. The study started on 2024-03-01. Estimated completion is 2028-09-14.
What conditions does trial NCT06192316 study?
This clinical trial studies the following conditions: Behavior, Risk.
What interventions are being tested in trial NCT06192316?
The interventions under investigation include: 3x3 between-subjects experimental exposure (BEHAVIORAL).
Who is sponsoring clinical trial NCT06192316?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06192316 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Behavior, Risk
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06192316's enrollment target sits among peer trials
450 225th of 2000 higher than 1,769 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
- NCT03269630 · 450 participants
New Orleans Pulmonary Hypertension Biobank
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI